Use of combination of an epidermal growth factor receptor...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/06 (2006.01) A61K 31/47 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2533126

This invention discloses combinations comprising a cytotoxic agent and an EGFR kinase inhibitor, and methods of treating or inhibiting cancer in a mammal in I need thereof which comprises administering to said mammal an effective amount of a cytotoxic agent and an EGFR kinase inhibitor.

L'invention concerne des mélanges contenant un agent cytotoxique et un inhibiteur de la kinase du récepteur de facteur de croissance épidermique, ainsi que des méthodes de traitement ou d'inhibition d'un cancer chez un mammalien le nécessitant. Ces méthodes consistent à administrer audit mammalien une quantité efficace d'un agent cytotoxique et d'un inhibiteur de la kinase du récepteur de facteur de croissance épidermique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of combination of an epidermal growth factor receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of combination of an epidermal growth factor receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of combination of an epidermal growth factor receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1852599

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.